Hansa Medical drug allows kidney transplantation in tough cases

LONDON (Reuters) - An experimental drug from Sweden's Hansa Medical has allowed doctors to perform successful kidney transplants in 24 out of 25 patients with a particularly high risk of organ rejection, researchers said on Wednesday.